Accelerate Drug Discovery and Development
Industry-approved fluidic-free standard for label-free molecular interaction analysis
Drug Development
Accelerating Flow Cytometry's Potential for Drug Screening
New applications also provide a boost for the technique's possible use in subcellular characterization
A Novel Technique to Automate Pharmaceutical Compound Production
Demonstrating the novel technique on prexersatib, research team achieves a fully automated six-step synthesis with 65 percent isolated yield within 32 hours
Chemical 'Nose' Sniffs Critical Differences in DNA Structures
Detection innovation could enhance drug development and cancer research
Lonza Celebrates 20th Anniversary of Nucleofector™ Cell Transfection Platform
The Nucleofector™ System offers a flexible, reliable approach to transfection, including for primary cells, which are typically hard to transfect
Simplifying Management of Complex Crystal Structure Prediction Data
New CSD-Theory software enables organizations to incorporate and share CSP data earlier and more easily, reducing risk and shortening the time to market for small molecule drug development
Designing Better Antibody Drugs with Artificial Intelligence
Scientists have now developed a machine learning method that supports the antibody optimization phase, helping to develop more effective antibody drugs
Using Genetics to ID Potential Drugs for COVID-19 Treatment
Based on their analyses, researchers call for prioritizing clinical trials of drugs targeting the proteins IFNAR2 and ACE2 to treat COVID-19 in its early stages
A New Automated Nanoparticle System for Formulation Library Generation
This next-generation automated platform aims to solve the challenges commonly associated with batch production of lipid nanoparticles and liposomes for drug and vaccine development
AI Method for Generating Proteins Will Speed Drug Development
AI-based method offers potential for many future applications, such as faster and more cost-efficient development of protein-based drugs